Cargando…

Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography

Programmed cell death‐1 (PD‐1) and programmed cell death‐ligand 1 (PD‐L1) have been identified as novel targets of immunotherapy of lung cancer. In present study, we evaluated the metabolic characteristics of lung cancer by using (18)F‐fluorodeoxyglucose positron emission tomography/computed tomogra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takada, Kazuki, Toyokawa, Gouji, Okamoto, Tatsuro, Baba, Shingo, Kozuma, Yuka, Matsubara, Taichi, Haratake, Naoki, Akamine, Takaki, Takamori, Shinkichi, Katsura, Masakazu, Shoji, Fumihiro, Honda, Hiroshi, Oda, Yoshinao, Maehara, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673920/ https://www.ncbi.nlm.nih.gov/pubmed/28980429 http://dx.doi.org/10.1002/cam4.1215

Ejemplares similares

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis
por: Takamori, Shinkichi, et al.
Publicado: (2018)

Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression
por: Takada, Kazuki, et al.
Publicado: (2017)

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients
por: Katsura, Masakazu, et al.
Publicado: (2017)

Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC
por: Toyozawa, Ryo, et al.
Publicado: (2020)

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
por: Shimokawa, Mototsugu, et al.
Publicado: (2022)

The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial–mesenchymal transition in resected lung adenocarcinoma
por: Matsubara, Taichi, et al.
Publicado: (2019)

Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study
por: Takada, Kazuki, et al.
Publicado: (2020)

Gut microbiota diversity and specific composition during immunotherapy in responders with non-small cell lung cancer
por: Shoji, Fumihiro, et al.
Publicado: (2022)

Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer
por: Shoji, Fumihiro, et al.
Publicado: (2020)

Impact of Preoperative Immunonutritional Support in Patients Undergoing Elective Thoracic Surgery
por: Shoji, Fumihiro, et al.
Publicado: (2021)

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date
por: Akamine, Takaki, et al.
Publicado: (2018)

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients
por: Haratake, Naoki, et al.
Publicado: (2019)

Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients with Comorbidities
por: Miura, Naoko, et al.
Publicado: (2020)

Cumulative experience of the anterior approach in robot-assisted thoracic surgery for lung cancer patients
por: Yamazaki, Koji, et al.
Publicado: (2021)

ALK‐positive lung cancer in a patient with recurrent brain metastases and meningeal dissemination who achieved long‐term survival of more than seven years with sequential treatment of five ALK‐inhibitors: A case report
por: Yamamoto, Keisuke, et al.
Publicado: (2021)

Significance of spread through air spaces in early‐stage lung adenocarcinomas undergoing limited resection
por: Toyokawa, Gouji, et al.
Publicado: (2018)

Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer
por: Takamori, Shinkichi, et al.
Publicado: (2020)

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab
por: Matsubara, Taichi, et al.
Publicado: (2020)

Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report
por: Miura, Naoko, et al.
Publicado: (2020)

Dramatic response to pembrolizumab with chemotherapy followed by salvage surgery in a lung cancer patient
por: Saito, Shunichi, et al.
Publicado: (2021)

Resection of Pulmonary Metastases 12 Years after Initial Surgery for a Benign Pheochromocytoma
por: Ueda, Michiko, et al.
Publicado: (2020)

Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study)
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Impact of the pretreatment prognostic nutritional index on the survival after first‐line immunotherapy in non‐small‐cell lung cancer patients
por: Oku, Yuka, et al.
Publicado: (2023)

Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status
por: Matsubara, Taichi, et al.
Publicado: (2021)

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy
por: Matsubara, Taichi, et al.
Publicado: (2021)

IgG4-Related Lung Disease Exhibiting the Invasion into the Diaphragm: A Case Report
por: Ono, Yuki, et al.
Publicado: (2020)

Role of fluorine-18-fluorodeoxyglucose positron emission tomography in selecting candidates for a minimally invasive approach for thymic epithelial tumour resection
por: Akamine, Takaki, et al.
Publicado: (2023)

Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient
por: Takamori, Shinkichi, et al.
Publicado: (2020)

Bilateral Diffuse Fluorodeoxyglucose Uptake in Thyroid Gland Diagnosed by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
por: Win, Aung Zaw, et al.
Publicado: (2014)

Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Disseminated Cryptococcosis
por: Tripathy, Sarthak, et al.
Publicado: (2017)

Weakly-supervised learning for lung carcinoma classification using deep learning
por: Kanavati, Fahdi, et al.
Publicado: (2020)

Correspondence Regarding “Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study”
por: Takada, Kazuki, et al.
Publicado: (2023)

Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors
por: Iwamuro, Masaya, et al.
Publicado: (2020)

Sarcoid reaction associated with Merkel cell carcinoma revealed by fluorodeoxyglucose positron emission tomography: a case report
por: Higashi, Yuko, et al.
Publicado: (2011)

Conservative treatment for residual lung congestion after left upper trisegmentectomy: a case report
por: Nagano, Taichi, et al.
Publicado: (2023)

The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational Cholangiocarcinoma
por: Kinoshita, Masahiko, et al.
Publicado: (2018)

Comparison of (18)F-fluorothymidine Positron Emission Tomography/Computed Tomography and (18)F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Breast Cancer
por: Mori, Mio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_atvrji9ehninpsrt279avprhdh